Pilat S - Search Results

1

A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.

Pazdur R, Ajani JA, Winn R, Bearden J, Belt RJ, Pilat S, Hallinan R, Levin B. Pazdur R, et al. Among authors: pilat s. Cancer. 1992 Feb 15;69(4):878-82. doi: 10.1002/1097-0142(19920215)69:4<878::aid-cncr2820690407>3.0.co;2-0. Cancer. 1992. PMID: 1735078 Clinical Trial.

2

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B. Pazdur R, et al. Among authors: pilat s. Cancer. 1992 Oct 15;70(8):2073-6. doi: 10.1002/1097-0142(19921015)70:8<2073::aid-cncr2820700810>3.0.co;2-a. Cancer. 1992. PMID: 1394037 Clinical Trial.

3

Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.

Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R. Wu HH, et al. Cancer. 2003 Dec 1;98(11):2410-9. doi: 10.1002/cncr.11810. Cancer. 2003. PMID: 14635076 Free article. Clinical Trial.

4

Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndrome.

Kurzrock R, Kantarjian HM, Blascovich MA, Bucher C, Verstovsek S, Wright JJ, Pilat SR, Cortes JE, Estey EH, Giles FJ, Beran M, Sebti SM. Kurzrock R, et al. Among authors: pilat sr. Clin Cancer Res. 2008 Jan 15;14(2):509-14. doi: 10.1158/1078-0432.CCR-07-1532. Clin Cancer Res. 2008. PMID: 18223226 Clinical Trial.

5

Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.

Logothetis CJ, Dexeus FH, Chong C, Sella A, Ayala AG, Ro JY, Pilat S. Logothetis CJ, et al. Among authors: pilat s. J Urol. 1989 Jan;141(1):33-7. doi: 10.1016/s0022-5347(17)40578-7. J Urol. 1989. PMID: 2908950

6

Pentostatin therapy of T-cell lymphomas with cutaneous manifestations.

Kurzrock R, Pilat S, Duvic M. Kurzrock R, et al. Among authors: pilat s. J Clin Oncol. 1999 Oct;17(10):3117-21. doi: 10.1200/JCO.1999.17.10.3117. J Clin Oncol. 1999. PMID: 10506607 Clinical Trial.

7

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R. Tsimberidou AM, et al. Among authors: pilat s. Ann Oncol. 2005 Jan;16(1):139-45. doi: 10.1093/annonc/mdi007. Ann Oncol. 2005. PMID: 15598951 Free article. Clinical Trial.

8

Pilot study of low-dose interleukin-11 in patients with bone marrow failure.

Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M. Kurzrock R, et al. Among authors: pilat s. J Clin Oncol. 2001 Nov 1;19(21):4165-72. doi: 10.1200/JCO.2001.19.21.4165. J Clin Oncol. 2001. PMID: 11689585 Clinical Trial.

9

BCR rearrangement-negative chronic myelogenous leukemia revisited.

Kurzrock R, Bueso-Ramos CE, Kantarjian H, Freireich E, Tucker SL, Siciliano M, Pilat S, Talpaz M. Kurzrock R, et al. Among authors: pilat s. J Clin Oncol. 2001 Jun 1;19(11):2915-26. doi: 10.1200/JCO.2001.19.11.2915. J Clin Oncol. 2001. PMID: 11387365

10

JAK1 Genomic Alteration Associated With Exceptional Response to Siltuximab in Cutaneous Castleman Disease.

Patel M, Ikeda S, Pilat SR, Kurzrock R. Patel M, et al. Among authors: pilat sr. JAMA Dermatol. 2017 May 1;153(5):449-452. doi: 10.1001/jamadermatol.2016.5554. JAMA Dermatol. 2017. PMID: 28241173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters